Epicardial fat inflammation response to COVID-19 therapies.

Gianluca IacobellisAlexis Elias MalavazosSara BasilicoSilvia TresoldiRocco Francesco RinaldoCarola DubiniGloria CapitanioFrancesca SerpiSimone SchiaffinoOmar Alessandro OlivaMaurizio CariatiLelio MorriconeStefano CentanniFrancesco SardanelliMichele CarrubaMassimiliano Marco Corsi RomanelliFrancesco Secchi

Published in: Obesity (Silver Spring, Md.) (2021)

Dexamethasone therapy was associated with significant reduction of EAT inflammation in COVID-19 patients, whereas SAT showed no changes. Anti-inflammatory therapies targeting visceral fat may be helpful in COVID-19.

Keyphrases

sars cov
coronavirus disease
oxidative stress
adipose tissue
anti inflammatory
respiratory syndrome coronavirus
insulin resistance
fatty acid
low dose
metabolic syndrome
mesenchymal stem cells
smoking cessation